©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 21, 2011; 17(11): 1494-1500
Published online Mar 21, 2011. doi: 10.3748/wjg.v17.i11.1494
Published online Mar 21, 2011. doi: 10.3748/wjg.v17.i11.1494
Table 2 Baseline Characteristics-27 patients who underwent primary prophylaxis
| Clinical characteristics | Number | % |
| No. of patients (male/female) | 27(21/6) | 71.4/28.6 |
| Mean age (yr) | 55.29 | |
| Etiology of gastric varices | ||
| Liver cirrhosis | 27 | 100 |
| Hepatitis B | 14 | 51.9 |
| Hepatitis C | 3 | 11.1 |
| Alcoholic | 6 | 22.2 |
| Unknown | 4 | 14.8 |
| Association of hepatocellular carcinoma | 5 | 18.5 |
| Child-Pugh classification (A/B/C) | 12/11/4 | 44.4/40.7/14.9 |
| Sarin classification of gastro-esophageal varices | ||
| GOV1 | 15 | 55.6 |
| GOV2 | 10 | 37 |
| IGV1 | 2 | 7.4 |
| IGV2 | 0 | 0 |
| Form of gastric varices | ||
| F1 | 3 | 11.1 |
| F2 | 9 | 33.3 |
| F3 | 15 | 55.6 |
- Citation: Kang EJ, Jeong SW, Jang JY, Cho JY, Lee SH, Kim HG, Kim SG, Kim YS, Cheon YK, Cho YD, Kim HS, Kim BS. Long-term result of endoscopic Histoacryl® (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices. World J Gastroenterol 2011; 17(11): 1494-1500
- URL: https://www.wjgnet.com/1007-9327/full/v17/i11/1494.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i11.1494